Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen: http://doi.org/10.25358/openscience-7180
Autoren: Galle, Peter R.
Foerster, Friedrich
Kudo, Masatoshi
Chan, Stephen L.
Llovet, Josep M.
Qin, Shukui
Schelman, William R.
Chintharlapalli, Sudhakar
Abada, Paolo B.
Sherman, Morris
Zhu, Andrew X.
Titel: Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Online-Publikationsdatum: 20-Jun-2022
Erscheinungsdatum: 2019
Sprache des Dokuments: Englisch
Zusammenfassung/Abstract: Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related deaths globally due, in part, to the majority of patients being diagnosed with intermediate or advanced stage disease. Our increased understanding of the heterogeneous molecular pathogenesis of HCC has led to significant developments in novel targeted therapies. Despite these advances, there remains a high unmet need for new treatment options. HCC is a complex disease with multiple pathogenic mechanisms caused by a variety of risk factors, making it difficult to characterize with a single biomarker. In fact, numerous biomarkers have been studied in HCC, but alpha-fetoprotein (AFP) remains the most widely used and accepted serum marker since its discovery over 60 years ago. This review summarizes the most relevant studies associated with the regulation of AFP at the gene and protein levels; the pathophysiology of AFP as a pro-proliferative protein; and the correlation of AFP with molecular HCC subclasses, the vascular endothelial growth factor pathway and angiogenesis. Also described are the historical and current uses of AFP for screening and surveillance, diagnosis, its utility as a prognostic and predictive biomarker and its role as a tumour antigen in HCC. Taken together, these data demonstrate the relevance of AFP for patients with HCC and identify several remaining questions that will benefit from future research.
DDC-Sachgruppe: 610 Medizin
610 Medical sciences
Veröffentlichende Institution: Johannes Gutenberg-Universität Mainz
Organisationseinheit: FB 04 Medizin
Veröffentlichungsort: Mainz
ROR: https://ror.org/023b0x485
DOI: http://doi.org/10.25358/openscience-7180
Version: Published version
Publikationstyp: Zeitschriftenaufsatz
Nutzungsrechte: CC BY
Informationen zu den Nutzungsrechten: https://creativecommons.org/licenses/by/4.0/
Zeitschrift: Liver international
39
12
Seitenzahl oder Artikelnummer: 2214
2229
Verlag: Wiley-Blackwell
Verlagsort: Oxford
Erscheinungsdatum: 2019
ISSN: 1478-3231
DOI der Originalveröffentlichung: 10.1111/liv.14223
Enthalten in den Sammlungen:JGU-Publikationen

Dateien zu dieser Ressource:
  Datei Beschreibung GrößeFormat
Miniaturbild
biology_and_significance_of_a-20220620120208132.pdf932.07 kBAdobe PDFÖffnen/Anzeigen